Barclays’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.1K | Sell |
3,339
-24,313
| -88% | -$449K | ﹤0.01% | 4170 |
|
|
2025
Q4 | $380K | Buy |
27,652
+2,164
| +8% | +$33.7K | ﹤0.01% | 4009 |
|
|
2025
Q3 | $451K | Sell |
25,488
-9,160
| -26% | -$145K | ﹤0.01% | 3875 |
|
|
2025
Q2 | $523K | Buy |
34,648
+7,834
| +29% | +$130K | ﹤0.01% | 3737 |
|
|
2025
Q1 | $431K | Sell |
26,814
-6,067
| -18% | -$113K | ﹤0.01% | 3615 |
|
|
2024
Q4 | $572K | Buy |
32,881
+2,575
| +8% | +$45.4K | ﹤0.01% | 3743 |
|
|
2024
Q3 | $532K | Buy |
30,306
+23,738
| +361% | +$405K | ﹤0.01% | 3736 |
|
|
2024
Q2 | $73.5K | Sell |
6,568
-4,756
| -42% | -$44.8K | ﹤0.01% | 4051 |
|
|
2024
Q1 | $98.6K | Sell |
11,324
-10,854
| -49% | -$99.8K | ﹤0.01% | 4441 |
|
|
2023
Q4 | $271K | Buy |
22,178
+19,187
| +641% | +$133K | ﹤0.01% | 4273 |
|
|
2023
Q3 | $12.1K | Sell |
2,991
-248
| -8% | -$1.54K | ﹤0.01% | 4274 |
|
|
2023
Q2 | $23.3K | Buy |
3,239
+3,050
| +1,614% | +$19.5K | ﹤0.01% | 4106 |
|
|
2023
Q1 | $635 | Sell |
189
-12
| -6% | -$36 | ﹤0.01% | 4942 |
|
|
2022
Q4 | $557 | Sell |
201
-16
| -7% | -$36 | ﹤0.01% | 5148 |
|
|
2022
Q3 | $0 | Sell |
217
-236
| -52% | -$383 | ﹤0.01% | 5058 |
|
|
2022
Q2 | $1K | Sell |
453
-1,806
| -80% | -$4.54K | ﹤0.01% | 4947 |
|
|
2022
Q1 | $11K | Sell |
2,259
-14,629
| -87% | -$120K | ﹤0.01% | 4586 |
|
|
2021
Q4 | $251K | Buy |
16,888
+11,202
| +197% | +$223K | ﹤0.01% | 3487 |
|
|
2021
Q3 | $123K | Buy |
5,686
+3,819
| +205% | +$82.2K | ﹤0.01% | 3825 |
|
|
2021
Q2 | $31K | Sell |
1,867
-10,003
| -84% | -$190K | ﹤0.01% | 4354 |
|
|
2021
Q1 | $282K | Buy |
11,870
+7,448
| +168% | +$223K | ﹤0.01% | 3539 |
|
|
2020
Q4 | $105K | Sell |
4,422
-1,928
| -30% | -$30.7K | ﹤0.01% | 4112 |
|
|
2020
Q3 | $75K | Sell |
6,350
-1,251
| -16% | -$13.5K | ﹤0.01% | 4396 |
|
|
2020
Q2 | $79K | Buy |
7,601
+3,854
| +103% | +$34.7K | ﹤0.01% | 4673 |
|
|
2020
Q1 | $27K | Sell |
3,747
-7,502
| -67% | -$77.8K | ﹤0.01% | 5538 |
|
|
2019
Q4 | $151K | Buy |
11,249
+5,659
| +101% | +$80.6K | ﹤0.01% | 5232 |
|
|
2019
Q3 | $87K | Sell |
5,590
-1,658
| -23% | -$21.5K | ﹤0.01% | 5580 |
|
|
2019
Q2 | $96K | Buy |
7,248
+4,182
| +136% | +$57.1K | ﹤0.01% | 5727 |
|
|
2019
Q1 | $54K | Buy |
3,066
+3,040
| +11,692% | +$47.7K | ﹤0.01% | 5822 |
|
|
2018
Q4 | $0 | Sell |
26
-4,413
| -99% | -$53.4K | ﹤0.01% | 7239 |
|
|
2018
Q3 | $63K | Buy |
4,439
+3,640
| +456% | +$51.7K | ﹤0.01% | 5922 |
|
|
2018
Q2 | $12K | Sell |
799
-1,122
| -58% | -$19K | ﹤0.01% | 6469 |
|
|
2018
Q1 | $25K | Buy |
1,921
+453
| +31% | +$8.6K | ﹤0.01% | 6340 |
|
|
2017
Q4 | $35K | Sell |
1,468
-6,021
| -80% | -$142K | ﹤0.01% | 5972 |
|
|
2017
Q3 | $139K | Buy |
7,489
+5,958
| +389% | +$135K | ﹤0.01% | 4695 |
|
|
2017
Q2 | $53K | Sell |
1,531
-3,569
| -70% | -$98.1K | ﹤0.01% | 5330 |
|
|
2017
Q1 | $104K | Buy |
+5,100
| New | +$69.4K | ﹤0.01% | 4851 |
|
Other funds holding PLSE
VCM
PCM
GAM
LP
Barclays's PLSE Position: Q1 2026 in Review
Barclays reduced its Pulse Biosciences (PLSE) stake by 88% in Q1 2026, selling an estimated $449K and leaving 3,339 shares worth $72.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4170.
Barclays first reported a position in PLSE in Q1 2017 and has held it in 37 quarters since. The position peaked at $572K in Q4 2024. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- Barclays held 3,339 shares of Pulse Biosciences worth $72.1K as of Q1 2026.
- Barclays sold 24,313 Pulse Biosciences shares in Q1 2026, an estimated $449K.
- Pulse Biosciences made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4170 holding.
- Barclays first reported a position in Pulse Biosciences in Q1 2017 and has held it in 37 quarters since.
- Barclays's Pulse Biosciences position peaked at $572K in Q4 2024.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.